Attenuation of the natural course of herpes simplex virus infection in human oral epithelial cell cultures by smokeless tobacco extracts suggests the possibility of a synergistic mechanism for carcinogenesis

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 81, Issue 1, 1996, Pages 63-69

  Murrah, Valerie A ^a   Gilchrist, Eric P ^a   Moyer, Mary Pat ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLANT EXTRACT;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; CELL CULTURE; CELL TRANSFORMATION; CERCOPITHECUS; COCARCINOGENESIS; CYTOPATHOGENIC EFFECT; DRUG EFFECT; EPITHELIUM; HERPES SIMPLEX VIRUS; HUMAN; MOUTH MUCOSA; MOUTH TUMOR; PATHOPHYSIOLOGY; PHYSIOLOGY; PLANT; SMOKELESS TOBACCO; STOMATITIS; VERO CELL; VIROLOGY; VIRUS CELL TRANSFORMATION; VIRUS REPLICATION;

ANALYSIS OF VARIANCE; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COCARCINOGENESIS; CYTOPATHOGENIC EFFECT, VIRAL; EPITHELIUM; HUMANS; MOUTH MUCOSA; MOUTH NEOPLASMS; PLANT EXTRACTS; PLANTS, TOXIC; SIMPLEXVIRUS; STOMATITIS, HERPETIC; TOBACCO, SMOKELESS; VERO CELLS; VIRUS REPLICATION;

EID: 0029678431     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1079-2104(96)80150-8     Document Type: Article

References (27)

1. Shillitoe EJ, Silverman S. Oral cancer and herpes simplex virus: a review. ORAL SURG ORAL MED ORAL PATHOL 1979;48:216-24.
2. Shillitoe EJ, Greenspan D, Greenspan JS, Hansen LS, Silverman S. Neutralizing antibody to herpes simplex virus type I in patients with oral cancer. Cancer 1982;49:2315-20.
3. Park K, Cherrick HM, Min B-M, Park N-H. Active HSV-1 immunization prevents the co-carcinogenic activity of HSV-1 in the oral cavity of hamsters. ORAL SURG ORAL MED ORAL PATHOL 1990;70:186-91.
4. Park N-H, Li S-L, Xie J-F, Cherrick HM. In vitro and animal studies of the role of viruses in oral carcinogenesis. Oral Oncol Eur J Cancer 1992;29:145-52.
5. Nahmias AJ, Noriid B. Oncogenic potential of herpes simplex viruses and their association with cervical neoplasia. In: Rapp F, ed. Oncogenic herpes viruses. Vol. 2. Boca Raton: CRC Press, 1980:25-45.
6. Hirsch J-M, Svennerholm B, Vahlne A. Inhibition of herpes simplex viral replication by tobacco extracts. Cancer Res 1984;44:1991-7.
7. Dokko H, Min PS, Cherrick HM, Park N-H. Effect of smokeless tobacco and tobacco-related chemical carcinogens on survival of ultraviolet light-inactivated herpes simplex virus. ORAL SURG ORAL MED ORAL PATHOL 1991;71:464-8.
8. Larsson PA, Hirsch JM, Gronowitz JS, Vahine A. Inhibition of herpes simplex virus replication and protein synthesis by non-smoked tobacco, tobacco alkaloids, and nitrosamines. Arch Oral Biol 1992;37:969-78.
9. Silverman S, Shillitoe EJ. Etiology and predisposing factors in oral cancer. 3rd ed. Atlanta: American Cancer Society, 1990:8-10.
10. Winn DM, Blot WJ, Shy CM, Pickel LW, Toledo MA, Fraumeni JF Jr. Snuff dipping and oral cancer among women in the southern United States. N Engl J Med 1981;304:745-9.
11. Hecht SS, Chen CB, Hirota N, Ornaf RM, Tso TC, Hoffman D. Tobacco-specific nitrosamine formation from nicotine in vitro and during tobacco curing and carcinogenicity in strain-A mice. J Natl Cancer Inst 1978;60:819-24.
12. Hecht SS, Rivenson A, Braley J, DiBello J, Adams JD, Hoffman D. Induction of oral cavity tumors in F344 rats by tobacco-specific nitrosamines and snuff. Cancer Res 1986;46:4162-6.
13. Obi FO, Billett MA. Preferential binding of the carcinogen benzo(a)pyrene to proteins of the nuclear matrix. Carcinogenesis 1991;12:481-6.
14. Ernster VL. Trends in smoking, cancer risk, and cigarette promotion: current priorities for reducing tobacco exposure. Cancer 1988;62:1702-12.
15. Wynder EL, Hoffman D. Tobacco and health. N Engl J Med 1979;300:894.
16. Park N-H, Akoto-Amanfu E, Paik DI. Smokeless tobacco carcinogensis: the role of viral and other factors. CA Cancer J Clin 1988;38:248-56.
17. Larsson PA, Edström S, Westin T, Nordkvist A, Hirsch JM, Vahlne A. Tobacco consumption and antibodies against herpes simplex virus in patients with head and neck cancer. Int J Cancer 1991;49:14-8.
18. Nahmias A, Roizman B. Infection with herpes simplex viruses 1 and 2. N Engl J Med 1973;289:781-9.
19. Spruance SL. Pathogenesis of herpes simplex labialis: excretion of virus in the oral cavity. J Clin Microbiol 1984;19:675-9.
20. Ejercito PM, Kieff ED, Roizman B. Characterization of herpes simplex virus strains differing in their effects on social behavior of infected cells. J Gen Virol 1968;2:357-64.
21. Roizman B, Spear PG, Kieff ED. Herpes simplex viruses I and II: a biochemical definition. In: Pollard M, Persistent virus infections: perspectives in virology. Vol. 8. New York: Academic Press, 1972:129-69.
22. Murrah VA, Gilchrist EP, Moyer MP. Morphologic and growth effects of tobacco-associated chemical carcinogens and smokeless tobacco extracts on human oral epithelial cells in culture. ORAL SURG ORAL MED ORAL PATHOL 1993;75:323-32.
23. MacCallum DK, Lillie JH, Jepsen A, Arenholt-Bindslev D. The culture of oral epithelium. Int Rev Cytol 1987;109:313-30.
24. Oh JS, Cherrick HM, Park N-H. Effect of snuff extract on the replication and synthesis of viral DNA and proteins in cells infected with herpes simplex virus. J Oral Maxillofac Surg 1990;48:373-9.
25. Das CM, Zhang S, Shillitoe EJ. Expression of the mutagenic peptide of herpes simplex virus type 1 in virus infected cells. Virus Res 1994;34:97-114.
26. Das CM, Murrah VA, Zhang S, Wong G, Gilchrist EP, Shillitoe EJ. The effect on cell phenotype of the mutagenic peptide of the herpes simplex virus type-1. Oral Oncol Eur J Cancer 1995;31B;4:267-74.
27. Park N-H, Sapp JP, Herbosa EG. Oral cancer induced in hamsters with herpes simplex infection and simulated snuffdipping. ORAL SURG ORAL MED ORAL PATHOL 1986;62:164.